IMMUNOLIGHT
LIVE

Serial Number

98139888

Owner

Immunolight, LLC

Attorney

J. Derek Mason

Filing Date

Aug 18, 2023

Add to watchlist:

No watchlists yet
View on USPTO

IMMUNOLIGHT Trademark

Serial Number: 98139888

IMMUNOLIGHT is a trademark filed by Immunolight, LLC on August 18, 2023. The trademark is classified under Class 1 (Chemicals), Class 2 (Paints), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Immunolight, LLC (28 trademarks)

c/o Bodman PLC
Detroit, MI 48226

Entity Type: 16

Trademark Details

Filing Date

August 18, 2023

Registration Date

Not Registered

Published for Opposition

September 3, 2024

Goods & Services

Medical services for treating a disease, condition, or disorder by detection of intercellular communication; medical services for treating a disease, condition, or disorder by detection of intracellular communication; medical services for treating a disease, condition, or disorder by detection and propagation of intercellular communication; medical services for treating a disease, condition, or disorder by detection and propagation of intracellular communication; medical services for treating a disease, condition, or disorder by triggering of intercellular communication; medical services for treating a disease, condition, or disorder by triggering of intracellular communication; medical services for biological tissue regeneration; medical services for the treatment of pain; medical services for the treatment of inflammation; medical services for the treatment of brain disorders; medical services for the treatment of cancer; medical services for the treatment of autoimmune disease or disorders

Energy storage systems comprised of solar cells, photovoltaic cells and modules and any combination thereof; optical fibers for light or color transmission; optical communication networks comprised of optical fibers

Additives for altering color in cosmetic preparations, namely, coloring preparations and non-medicated skin care preparations; cosmetic preparations

Medical device for detection of biophotons; medical device for detection of intercellular communication; medical device for detection of intracellular communication; medical device for treating a disease, condition and disorder by detection of intercellular communication; medical device for treating a disease, condition and disorder by detection of intracellular communication; medical device for triggering of biophotons; medical device for detection of intercellular communication; medical device for triggering of intracellular communication; medical device for treating a disease, condition and disorder by triggering of intercellular communication; medical device for treating a disease, condition and disorder by triggering of intracellular communication

Pharmaceutical preparations for biological tissue regeneration; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of inflammation; pharmaceutical preparations for the treatment of brain disorders; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of autoimmune disease and disorders; pharmaceutical agents for treating a disease, condition, or disorder of the tissues of a subject by detecting and triggering biophotons; pharmaceutical agents for treating a disease, condition, and disorder of the tissues of a subject by detecting and triggering intercellular communication; pharmaceutical agents for treating a disease, condition, and disorder of the tissues of a subject by detecting and triggering intracellular communication; pharmaceutical preparations for treating a disease, condition, and disorder of the tissues of a subject by detecting and triggering biophotons; pharmaceutical preparations for treating a disease, condition, and disorder of the tissues of a subject by detecting and triggering intercellular communication; pharmaceutical preparations for treating a disease, condition, and disorder of tissues of a subject by detecting and triggering intracellular communication; preparations for sanitization and remediation of air supply, water supply, and biological materials for medical purposes

Powdered energy converting additives for altering color in paint, pigment, and colorant preparations; paint preparations in the nature of paints and coatings containing particulate energy converting additives; pigment preparations in the nature of pigments containing particulate energy converting additives; colorant preparations in the nature of colorants containing particulate energy converting additives.

Chemical additives for altering color in cosmetic preparations; substances in the nature of chemicals for use in solar cells and photovoltaic cells

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 29, 2026 EXRA
SOU EXTENSION 3 GRANTED
Apr 28, 2026 EX3G
SOU EXTENSION 3 FILED
Apr 28, 2026 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 28, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 18, 2025 EXRA
SOU EXTENSION 2 GRANTED
Sep 17, 2025 EX2G
SOU EXTENSION 2 FILED
Sep 17, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Sep 17, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 25, 2025 EXRA
SOU EXTENSION 1 GRANTED
Apr 25, 2025 EX1G
SOU EXTENSION 1 FILED
Apr 24, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 24, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Oct 29, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 3, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 3, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 14, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 31, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 24, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 24, 2024 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Jul 24, 2024 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 16, 2024 GNFN
FINAL REFUSAL E-MAILED
May 16, 2024 GNFR
FINAL REFUSAL WRITTEN
May 16, 2024 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 1, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 30, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 30, 2024 TROA
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Jan 30, 2024 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jan 30, 2024 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 31, 2023 GNRN
NON-FINAL ACTION E-MAILED
Oct 31, 2023 GNRT
NON-FINAL ACTION WRITTEN
Oct 31, 2023 CNRT
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 30, 2023 GNRN
NON-FINAL ACTION E-MAILED
Oct 30, 2023 GNRT
NON-FINAL ACTION WRITTEN
Oct 30, 2023 CNRT
ASSIGNED TO EXAMINER
Oct 26, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 18, 2023 NWOS
NEW APPLICATION ENTERED
Aug 22, 2023 NWAP